Clinical Trials
44 trialsA Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine
University of Arkansas
ECP
Centre Chirurgical Marie Lannelongue
LUNG-RESIST
University Hospital, Toulouse
KOBE
University Hospital, Toulouse
RESAMEX
Groupe Francais De Pneumo-Cancerologie
RICEPS-2
University Hospital, Tours
MetLung
Centre Oscar Lambret
PneumoTAV001
Grupo Español de Investigación en Diagnóstico y Tratamiento Hipertemprano de Enfermedades (GeDiTPhe)
Study of Early Cancer Biomarkers in Breath Condensate in Population of Individuals With High-Risk of Lung Cancer Undergoing LDCT Screening.
The Institute of Molecular and Translational Medicine, Czech Republic
BREATHE
Nantes University Hospital
CLASSE-P1
Assistance Publique - Hôpitaux de Paris
LUNGDOC
University Hospital, Montpellier
ULYSSE
Hospices Civils de Lyon
DECIDE
Institut Claudius Regaud
MADMAS
Hospices Civils de Lyon
Plasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benign Nodules
Hasselt University
CIRCUIT
University Hospital, Bordeaux
BCBPoumon
Institut du Cancer de Montpellier - Val d'Aurelle
PROGRESS
UNC Lineberger Comprehensive Cancer Center
The Safety and Feasibility of Costal Bone Marrow Aspiration During Thoracic Surgery
Universitair Ziekenhuis Brussel
EXODIAG
Centre Georges Francois Leclerc
ALCINA2
Institut du Cancer de Montpellier - Val d'Aurelle
Lymphocyte Depletion and Change in Lymphocyte Functionality
University of Virginia
CANTO
UNICANCER
ARIA
Scientific Institute San Raffaele
BIOCEPTION
Assistance Publique Hopitaux De Marseille
PREVALUNG*
Assistance Publique Hopitaux De Marseille
PROTEON
Centre Hospitalier Universitaire de Liege
Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis
Wake Forest University Health Sciences
HEPATICI
Centre Hospitalier Universitaire, Amiens
EMBRaCE-GM
Manchester University NHS Foundation Trust
Onco-PDL1s/B2M
University Hospital, Clermont-Ferrand
Metabolic and Microbial Profiling of Lung Cancer
Wake Forest University Health Sciences
ONCOPRO
Hospices Civils de Lyon
ECTOPIC/MUTAS
University Hospital, Grenoble
POIR
Centre Hospitalier Universitaire de Saint Etienne
Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma
GlaxoSmithKline
ALCAPONE
Centre Georges Francois Leclerc
NSCLC Heterogeneity in Early Stage Patients and Prediction of Relapse Using a Personalized "Liquid Biopsy"
Hellenic Oncology Research Group
The ISET (Isolation by Size of Epithelial Tumor Cells) and the CellSearch Methods in Malignant Pleural Mesothelioma
Centre Hospitalier Universitaire de Nice
MSN
Gustave Roussy, Cancer Campus, Grand Paris
CIRCUBRONCH
Central Hospital, Nancy, France
Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy
University of Miami
Tumor Markers in Lung Cancer: DCAMLK-1LK-1
University of Oklahoma